Takeda to Initiate World’s First Norovirus Vaccine Field Trial

Takeda has initiated a clinical trial testing the potential of the world’s first experimental vaccine for norovirus, which is responsible for nearly three quarters of a billion illnesses and 219,000 deaths each year around the globe. The Phase IIb, double-blind, randomised, placebo-controlled study will be assessing the efficacy of the candidate – via intramuscular administration

Continue Reading

Jardiance Reduces Risk of Progressive Kidney Disease in Patients with Type 2 Diabetes

New data showed Jardiance reduced the risk of new-onset or worsening kidney disease by 39% versus placebo when added to standard care in adults with type 2 diabetes with established cardiovascular disease. Boehringer Ingelheim and Lilly announced the findings at the American Diabetes Association (ADA) 76th Scientific Sessions in New Orleans early in the month.

Continue Reading

Ryboquin Raises £1.3m for Cancer Drug Development

A Scottish Borders-based pharmaceutical firm, Ryboquin has raised £1.3m towards cancer gene therapy drug development. The money will allow Ryboquin Ltd to take the product – named Ryboquin ECP-102 – one step closer to clinical trials. The firm, which has its headquarters in Selkirk, raised £800,000 from investors plus nearly £500,000 in a Scottish Enterprise

Continue Reading

J+J Announce Collaboration to Create Personalised Healthcare Solutions with 3D Printing

Today Johnson & Johnson announced a collaboration between Johnson & Johnson Services, Inc. and a subsidiary of HP Inc. The partnership will be focused on using 3D printing technologies to create better healthcare outcomes at a reduced cost. By working together, the companies plan to combine their scientific, clinical, material science and technological expertise to

Continue Reading

Pfizer to Test Cancer Immunotherapy Combination

Pfizer is reportedly gearing up to test a combination of three cancer drugs in human trials next year. According to the Financial Times, the trial, which will be one of the first to test a trio of immunotherapies, will monitor the safety and efficacy of the combination in patients with solid cancers. Although current immunotherapies

Continue Reading

Are You Paid Enough?

In our 2016 Life Science Salary Survey, we have discovered that a staggering 49% of UK Pharmaceutical Physicians believe that their salary does not reflect their current career level. Although the majority believed otherwise, it still shows significant discord and lack of confidence in salaries within the Life Science industry. Whatever the change in career,

Continue Reading